Targeted Jak Inhibitor Tablets for Canine Atopic Dermatitis & Pruritus Control

Targeted Jak Inhibitor Tablets for Canine Atopic Dermatitis & Pruritus Control. Rapid Itch Relief: Onset of action within 4 hours, reaching peak plasma concentration in 1 hour. Targeted JAK Inhibition: Selectively inhibits JAK1 and JAK3 without affecting hematopoietic JAK2 cytokines. Non-Hormonal Formula: Contains no corticosteroids or antihistamines; a safe targeted immunomodulator. High Bioavailability: Absolute bioavailability of 89% with rapid and complete absorption. Generic Cost-Effectiveness: Same active ingredient as Apoquel but with better cost-effectiveness. Flexible Administration: May be given with or without food; food does not significantly affect absorption. Excellent Palatability: Chewable tablets have excellent taste, allowing dogs to take them voluntarily. Wide Strength Range: Available in 3.6mg, 5.4mg, and 16mg strengths for dogs weighing 3.0-80.0 kg.